Search Results
Institute of Cancer Research,, The Garvan Institute of Medical Research,, The Breakthrough Breast Cancer Research Centre, 237 Fulham Road, London SW3 6JB, UK
Search for other papers by Kara Britt in
Google Scholar
PubMed
Search for other papers by Alan Ashworth in
Google Scholar
PubMed
Search for other papers by Matthew Smalley in
Google Scholar
PubMed
Introduction The only factor known to consistently decrease lifetime breast cancer risk regardless of ethnicity is early childbirth ( MacMahon et al . 1970 , Henderson et al . 1974 , Kelsey et al . 1993 ). Women who have undergone a first full
Search for other papers by Manami Inoue in
Google Scholar
PubMed
Search for other papers by Shoichiro Tsugane in
Google Scholar
PubMed
Introduction A substantial body of epidemiological evidence over recent decades has suggested a positive link between excess bodyweight and type 2 diabetes mellitus (DM) and many types of cancer. Studies have also suggested an inverse association
Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Amsterdam, the Netherlands
Search for other papers by Tesa M Severson in
Google Scholar
PubMed
Search for other papers by Wilbert Zwart in
Google Scholar
PubMed
Introduction Male breast cancer is rare, accounting for around 1% of all breast cancers ( Siegel et al. 2016 ) and is frequently positive for ERα (91–95%) and/or PR (80–81%) ( Giordano et al. 2004 , Anderson et al. 2010 , Nilsson et
Search for other papers by Tung Hoang in
Google Scholar
PubMed
Search for other papers by Quy Nguyen Ngoc in
Google Scholar
PubMed
Search for other papers by Jeonghee Lee in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by Yul Hwangbo in
Google Scholar
PubMed
Search for other papers by Jeongseon Kim in
Google Scholar
PubMed
Introduction Thyroid cancer remains the ninth most common cancer worldwide, accounting for an estimated 567,000 cases in 2018 ( Bray et al. 2018 ). According to the national cancer data updated by the National Center Cancer Registry of Korea
Search for other papers by Sunmi Park in
Google Scholar
PubMed
Search for other papers by Mark C Willingham in
Google Scholar
PubMed
Search for other papers by Jun Qi in
Google Scholar
PubMed
Search for other papers by Sheue-Yann Cheng in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine malignancy. It consists of an array of different histologic and biologic types, but the most common are differentiated thyroid carcinomas (DTCs). While the overall survival of patients
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Steven M Hill in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Victoria P Belancio in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Robert T Dauchy in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Shulin Xiang in
Google Scholar
PubMed
Search for other papers by Samantha Brimer in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Lulu Mao in
Google Scholar
PubMed
Search for other papers by Adam Hauch in
Google Scholar
PubMed
Search for other papers by Peter W Lundberg in
Google Scholar
PubMed
Search for other papers by Whitney Summers in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Lin Yuan in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Tripp Frasch in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by David E Blask in
Google Scholar
PubMed
environmental changes. Similarly, the multitude of processes that govern cancer initiation, promotion, and progression, including invasion and metastasis, are temporally modulated by the host's circadian rhythmic outputs from the central circadian pacemaker in
Search for other papers by Phungern Khongthong in
Google Scholar
PubMed
Search for other papers by Antonia K Roseweir in
Google Scholar
PubMed
Search for other papers by Joanne Edwards in
Google Scholar
PubMed
Introduction Oestrogen receptor α-positive (ER+) breast cancer constitutes more than 70% of all breast cancers ( Cardoso et al. 2012 ). Both early and metastatic disease are treated effectively with endocrine therapies, which downregulate
Search for other papers by Robert C Smallridge in
Google Scholar
PubMed
Search for other papers by Laura A Marlow in
Google Scholar
PubMed
Search for other papers by John A Copland in
Google Scholar
PubMed
Incidence Thyroid cancers, while uncommon, are increasing in prevalence in this country due, at least in part, to earlier detection from imaging. In 2008, there are estimated to be 37 340 new cases, with 1590 deaths ( Jemal et al . 2008
Search for other papers by Xianhui Ruan in
Google Scholar
PubMed
Search for other papers by Xianle Shi in
Google Scholar
PubMed
Search for other papers by Qiman Dong in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Xiukun Hou in
Google Scholar
PubMed
Search for other papers by Xinhao Song in
Google Scholar
PubMed
Search for other papers by Xi Wei in
Google Scholar
PubMed
Search for other papers by Lingyi Chen in
Google Scholar
PubMed
Search for other papers by Ming Gao in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer of endocrine system, with a rapid worldwide increase over recent decades ( Enewold et al. 2009 , Kilfoy et al. 2009 , Chen et al. 2016 ). The disease is classified into three types
Search for other papers by Shyh-Han Tan in
Google Scholar
PubMed
Search for other papers by Marja T Nevalainen in
Google Scholar
PubMed
, Kindblom et al . 2002 , 2003 ). Autocrine PRL in prostate and breast tissue became important findings, since local production of PRL provided an explanation as to why the results of studies trying to link breast or prostate cancer incidence or progression